Loading clinical trials...
Loading clinical trials...
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle- Controlled Study of the Safety, Tolerability, and Efficacy of 0.15% and 0.25% Concentrations of Topical SM04554 Solution in Male Subjects With Androgenetic Alopecia (AGA)
Conditions
Interventions
SM04554
Vehicle
Locations
24
United States
Encinitas, California, United States
San Diego, California, United States
New Haven, Connecticut, United States
Miami, Florida, United States
West Palm Beach, Florida, United States
Plainfield, Indiana, United States
Start Date
November 1, 2014
Primary Completion Date
November 1, 2015
Completion Date
November 1, 2015
Last Updated
February 17, 2020
NCT07012486
NCT07011485
NCT07248410
NCT07155408
NCT06539273
NCT06118866
Lead Sponsor
Biosplice Therapeutics, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions